msadmin
Belgian techbio startup Sightera raises $3.2M for AI-designed molecular glues
Belgian AI drug discovery startup Sightera Biosciences raises $3.2M to advance molecular glue therapies for hard-to-treat cancers and fibrosis.
FPT launches MediSight AI framework for healthcare and life sciences
FPT launches MediSight, an AI-powered healthcare framework designed to accelerate digital transformation and regulatory compliance for healthcare and life sciences…
Boehringer Ingelheim taps Immunai AI platform in $15 million deal
Boehringer Ingelheim pays $15M for Immunai's AI platform to find shared T-cell targets across cancer and autoimmune disease.
New Zealand health system partners with NHS for AI scribe rollout
Te Whatu Ora partners with UCLPartners to gain evidence and confidence for AI scribe deployment across emergency departments.
Singapore launches national programme for foundation AI in healthcare
Singapore's SIMFONI programme will build foundation AI models for cardiometabolic care and eye disease, embedded into the national EMR system.
DeepMind unveils AI co-clinician research for triadic care model
Google DeepMind introduces the AI co-clinician initiative, envisioning AI agents that collaborate with physicians under clinical authority to deliver more…
Mount Sinai AI model maps how genes function together in cells
Scientists at Mount Sinai developed a gene set foundation model that learns how genes behave across thousands of biological contexts,…
Over 173 AI-designed drugs now in trials as FDA decision nears
More than 173 AI-originated drug programs are in clinical development as of early 2026, with the first potential FDA approval…